Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM17 | P78536 | 17/20 | 1.00 |
| ▸ | MMP13 | P45452 | 10/20 | 1.00 |
| ▸ | MMP2 | P08253 | 5/20 | 1.00 |
| ▸ | MMP9 | P14780 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6795271 | 0.99 | ADAM17 (1.00) | ADAM17MMP13MMP2MMP9 | |
| SCHEMBL6788849 | 0.98 | ADAM17 (1.00) | ADAM17MMP13MMP2MMP9 | |
| Trifluoroacetic Acid SCHEMBL6787337 | 0.95 | ADAM17 (0.91) | ADAM17MMP13MMP2MMP9 | |
| Trifluoroacetic Acid SCHEMBL6794294 | 0.94 | ADAM17 (0.91) | ADAM17MMP13MMP2MMP9 | |
| Trifluoroacetic Acid SCHEMBL6790603 | 0.94 | ADAM17 (0.91) | ADAM17MMP13MMP2MMP9 | |
| SCHEMBL6788301 | 0.93 | ADAM17 (0.91) | ADAM17MMP13MMP2MMP9 | |
| SCHEMBL6794665 | 0.93 | ADAM17 (1.00) | ADAM17MMP13MMP2MMP9 | |
| SCHEMBL6789566 | 0.92 | ADAM17 (1.00) | ADAM17MMP13MMP2MMP9 | |
| SCHEMBL5866623 | 0.91 | ADAM17 (0.84) | ADAM17MMP13MMP2MMP9 | |
| SCHEMBL6794673 | 0.91 | ADAM17 (1.00) | ADAM17MMP13MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6825215-B2 | N-HYDROXY-2-(2-(((4-((2-METHYL-4-QUINOLINYL)METHOXY)PHENYL) -SULFONYL)METHYL)-2-PYRROLIDINYL)ACETAMIDE, FOR EXAMPLE AND OTHER QUINOLINE CONTAINING N-HYDROXYACETAMIDE DERIVATIVES | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-11-30 | — | — | US | disclosed |